26 дек. 2023 г. · The 5-year overall survival was 79%, with patients undergoing surgery having a 90.6% 5-year survival. Multivariable analysis revealed age > 60 ...

Here the 5-year survival rates were 73.2%, 79.4% and 87.9% for localised cRCC, pRCC and chromophobe RCC. However, multivariate analyses only identified the TNM ...

The papillary subtype of renal cell carcinoma (pRCC) has a poorer prognosis when compared to their more common clear cell counterpart RCC (ccRCC). We wish to ...

In this study we assessed tumour characteristics and long-term prognosis of patients with pRCC in comparison with conventional clear-cell cancer (ccRCC).

2 нояб. 2021 г. · For type1 and type2 pRCC, 3-years PFS was 93.0% and 74.9%, respectively. Survival of type1 pRCC was better than that of type2 (P= 0.027).

Wells et al characterized the outcomes of 466 patients with metastatic p-RCC and found that the overall survival of patients with cc-RCC was 8 months longer ...

Waalkes et al. (28) reported that papillary RCC has a significantly better prognosis than clear cell RCC, which is inconsistent with our findings; there was no ...

12 февр. 2021 г. · This patient with metastatic type 2 PRCC could survive 80 months after the initial recurrence by multidisciplinary treatments including ...

4 июн. 2021 г. · Predictive nomogram for midterm to long-term prognosis in patients with papillary renal cell carcinoma based on data from the surveillance ...